Prof. Dr Yuan Xu | Biomaterials | Best Researcher Award

Prof. Dr Yuan Xu | Biomaterials | Best Researcher Award

Prof. Dr. Yuan Xu is a renowned physician-scientist and Chief Physician at the China-Japan Friendship Hospital ๐Ÿฅ. Holding both an MD and PhD, he specializes in the integration of Traditional Chinese Medicine (TCM) and Western medicine ๐Ÿ”ฌ๐ŸŒฑ. He serves as Deputy Director of the National Center for Integrated Medicine and is a Masterโ€™s Supervisor guiding future clinicians ๐ŸŽ“๐Ÿง‘โ€โš•๏ธ. As a former visiting scholar at Yale University, his global outlook informs research on rheumatology, fibromyalgia, and chronic disease care ๐ŸŒ๐Ÿ’ก. With 48 publications, 12 SCI papers, and multiple funded projects, he is a leader in translational healthcare innovation ๐Ÿง ๐Ÿ†.

Prof. Dr Yuan Xu, China-Japan Friendship Hospital, China

Profile

SCOPUS

Education ๐ŸŽ“

Prof. Dr. Yuan Xu holds both an MD and a PhD, establishing a strong foundation in clinical medicine and biomedical research ๐Ÿฉบ๐Ÿ”ฌ. His dual training bridges Western medical science and Traditional Chinese Medicine (TCM), enabling an integrative approach to healthcare ๐ŸŒ๐ŸŒฑ. He further enriched his academic profile as a visiting scholar at Yale University, USA, where he engaged in global research collaboration and advanced clinical studies ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ“–. This diverse educational background equips him with a comprehensive and holistic view of medicine, fueling his innovative work in rheumatology and chronic disease treatment ๐Ÿ’ก๐Ÿง .

Experience ๐Ÿฅ

Prof. Dr. Yuan Xu is a seasoned Chief Physician at the China-Japan Friendship Hospital and serves as a Masterโ€™s Supervisor, nurturing the next generation of clinicians and researchers ๐ŸŽ“๐Ÿ‘จโ€๐Ÿซ. As Deputy Director at the National Center for Integrated Traditional Chinese and Western Medicine, he leads national initiatives merging TCM with modern medical science โš•๏ธ๐ŸŒฟ. Recognized as an Innovative Young Talent and a โ€œNew 125โ€ TCM Leader, he also gained international exposure as a visiting scholar at Yale University ๐ŸŒ๐Ÿ“š. His career spans clinical care, policy leadership, and translational research in chronic disease management ๐Ÿง ๐Ÿฆด.

Contributions ๐Ÿ“–

Prof. Dr. Yuan Xu has made impactful contributions in three core research areas: the development of diagnostic and treatment protocols for rheumatoid arthritis using Traditional Chinese Medicine (TCM) ๐ŸŒฟ๐Ÿฆด, the advancement of fibromyalgia care strategies ๐Ÿง ๐Ÿ’Š, and the management of integrated TCM and Western medical systems ๐Ÿฅโš–๏ธ. He has led 12 major research projects, securing over 10 million yuan in funding ๐Ÿ’ฐ๐Ÿ“Š. His academic output includes 48 publications, with 12 SCI-indexed papers, where he served as first or corresponding author โœ๏ธ๐Ÿ”. His work bridges clinical care and scientific discovery in modern integrative medicine ๐Ÿงฌ๐Ÿฉบ.

Research Focus ๐Ÿ”ฌ

Prof. Dr. Yuan Xuโ€™s research primarily targets rheumatoid diseases, with a strong emphasis on rheumatoid arthritis and fibromyalgia syndrome ๐Ÿฆด๐Ÿงฌ. His work integrates Traditional Chinese Medicine (TCM) and modern biomedical approaches to develop more effective diagnostic models and personalized treatments ๐ŸŒฑโš•๏ธ. He investigates immune system dysregulation, inflammatory pathways, and syndrome differentiation in chronic joint disorders ๐Ÿ”๐Ÿ’Š. Through national and international collaborations, including with Yale University, he bridges ancient practices with advanced clinical research ๐Ÿฅ๐ŸŒ. His translational focus ensures that findings directly improve patient outcomes in chronic rheumatologic care ๐Ÿ“ˆ๐Ÿง‘โ€โš•๏ธ.

Publications ๐Ÿ“š

Early prediction of bone destruction in rheumatoid arthritis through machine learning analysis of plasma metabolites
Authors: Wang Zihan, Lan Tianyi, Jiao Yi, Tao Qingwen, Xu Yuan
Journal: Arthritis Research and Therapy, 2025 ๐Ÿง ๐Ÿ’‰๐Ÿ“Š

Clinical Characteristics and Influencing Factors of Rheumatoid Arthritis in Patients with Cold Dampness Obstruction Syndrome
Authors: Chen Yanyu, Li Yanqi, Liu Longxiao, Xu Yuan, Tao Qingwen
Journal: Chinese Journal of Experimental Traditional Medical Formulae, 2025 ๐ŸŒฟ๐Ÿฆด๐Ÿ“˜

Integrated phytochemistry and network pharmacology analysis to reveal effective substances and mechanisms of Bushen Quhan Zhiwang decoction in the treatment of rheumatoid arthritis
Authors: Zhang Liubo, Yan Yu, Ma Ru, Tao Qingwen, Xu Yuan
Journal: Journal of Ethnopharmacology, 2024 ๐ŸŒฑโš—๏ธ๐Ÿ”Ž

Prof. Dr Ramasamy Paulmurugan | Biomaterials | Best Researcher Award

Prof. Dr Ramasamy Paulmurugan | Biomaterials | Best Researcher Award

Prof. Dr. Ramasamy Paulmurugan is a globally recognized biomedical scientist and Professor of Radiology at Stanford University School of Medicine ๐Ÿ›๏ธ. With expertise in molecular imaging, nanomedicine, and gene therapy, his work focuses on cancer diagnostics and targeted therapeutics ๐ŸŽฏ๐Ÿงซ. He leads the Cellular Pathway Imaging Laboratory, developing cutting-edge biosensors and nanoparticle-based delivery systems ๐Ÿ’ก๐Ÿงช. Author of 145+ publications, he has received prestigious awards for innovation and research excellence ๐Ÿ…๐Ÿ“š. His interdisciplinary impact spans academia, clinical research, and biotechnology, making him a trailblazer in translational medicine and precision oncology ๐ŸŒโš•๏ธ.

Prof. Dr Ramasamy Paulmurugan, Stanford University, United States

Profile

SCOPUS

ORCID

GOOGLESCHOLAR

Education ย ๐ŸŽ“

Prof. Dr. Ramasamy Paulmurugan began his academic journey with a B.Sc. in Zoology, Botany, and Chemistry (1986โ€“1989) from Madurai Kamaraj University, India ๐Ÿธ๐ŸŒฟ๐Ÿงช. He pursued an M.Sc. in Biomedical Genetics (1989โ€“1991) at the University of Madras, developing a strong foundation in genetic science and human biology ๐Ÿงฌ๐Ÿง . He then earned a Ph.D. in Biomedical Genetics with specialization in Molecular Virology (1991โ€“1997) from National Environmental Engineering Research Institute and University of Madras, India ๐Ÿ”ฌ๐Ÿฆ . His education equipped him with the interdisciplinary knowledge and research skills essential for his impactful work in cancer biology and molecular medicine ๐Ÿ’กโš•๏ธ.

Honors & Awards ๐Ÿ…

Prof. Dr. Ramasamy Paulmurugan has received numerous prestigious awards throughout his career for outstanding contributions to biomedical science ๐Ÿงฌ๐Ÿง . His accolades include the Best Research Fellow Award (1991) from CSIR-NEERI ๐Ÿ‡ฎ๐Ÿ‡ณ, the Young Scientist Award (1999) from the Government of Kerala, and multiple Travel Awards from international imaging societies for best paper presentations in the USA and Germany โœˆ๏ธ๐Ÿ“„. He was honored with the Distinguished Investigator Award (2018) by the Academy for Radiology & Biomedical Imaging Research ๐Ÿงช and recently received the SAASCR Outstanding Achievement Award (2025) for advancing Asian American cancer research ๐ŸŒ๐Ÿ”ฌ.

Experience ย ๐Ÿฅ

Prof. Dr. Ramasamy Paulmurugan has over three decades of research and academic experience across India and the United States ๐ŸŒ. He began as a Junior and Senior Research Fellow in Molecular Virology in India (1991โ€“1996) ๐Ÿ”ฌ, later leading the Environmental Biotechnology Division at RGCB as Scientist B and C (1996โ€“1999, 1999โ€“2003) ๐Ÿงซ. He was a Visiting Scientist at UCLA (2001โ€“2003) ๐Ÿง , then joined Stanford University, where he advanced from Senior Research Scientist to Professor of Radiology (2003โ€“present) ๐Ÿ›๏ธ. His roles have spanned molecular imaging, translational research, and biomedical innovation across prestigious global institutions ๐Ÿ’ก๐Ÿ“ˆ.

Book Chapter ๐Ÿ“–

Prof. Dr. Ramasamy Paulmurugan has authored and co-authored over 27 book chapters, contributing to prestigious scientific volumes on molecular imaging, cancer biology, gene therapy, bioluminescence, and nanomedicine ๐Ÿ“–๐Ÿ”ฌ. His work spans publishers like Springer, Elsevier, Cambridge University Press, and World Scientific, reflecting his expertise in cutting-edge biomedical innovations ๐ŸŒ๐Ÿ“—. Topics include theranostics, glioblastoma resistance, protein-protein interaction imaging, microRNA therapy, and nanoparticle-based delivery systems for precision medicine ๐ŸŽฏ๐Ÿ’Š. His chapters are widely cited and used globally in advanced medical research, showcasing his status as a thought leader in translational and molecular medicine ๐Ÿงช๐ŸŒŸ.

Conference Presentations ๐ŸŒ๐ŸŽค

Prof. Dr. Ramasamy Paulmurugan has presented over 220 abstracts at leading international conferences spanning oncology, molecular imaging, nanomedicine, and gene therapy ๐Ÿงฌ๐Ÿง . His research has been showcased at AACR, WMIC, RSNA, IEEE, ASNR, and SPIE, reflecting sustained excellence and innovation across decades ๐Ÿ›๏ธ๐Ÿ”ฌ. Topics include molecular biosensors, microRNA therapy, nanoparticle delivery, ultrasound imaging, and cancer diagnostics. These presentations highlight collaborations with global experts and his role in pioneering translational research that bridges bench to bedside ๐Ÿงชโžก๏ธ๐Ÿฅ. His prolific and consistent contributions demonstrate global recognition and influence in biomedical innovation ๐ŸŒ๐Ÿ….

Research Focus ๐Ÿ”ฌ

Prof. Dr. Ramasamy Paulmuruganโ€™s research centers on molecular imaging, nanomedicine, and gene-based therapies to combat cancer and metabolic diseases like diabetes ๐Ÿง โš•๏ธ. He pioneers in vivo imaging of proteinโ€“protein interactions, miRNA delivery, and biosensor technologies for real-time monitoring of disease pathways ๐Ÿงฌ๐Ÿ“ธ. His innovations include split-luciferase systems, cell membrane-coated nanocarriers, and redox-sensitive signaling tools for precision therapeutics ๐ŸŽฏ๐Ÿงช. Bridging molecular biology with biomedical engineering, his translational research focuses on targeted drug delivery, noninvasive diagnostics, and theranostic nanoparticles, contributing significantly to personalized medicine and cancer theranostics ๐Ÿ’‰๐Ÿง ๐ŸŒ.

Publications ๐Ÿ“š

The fate and toxicity of Raman-active silica-gold nanoparticles in mice
Authors: A.S. Thakor, R. Luong, R. Paulmurugan, F.I. Lin, P. Kempen, C. Zavaleta, et al.
Journal: Science Translational Medicine, Vol. 3 (79), 79ra33

Noninvasive quantitative imaging of proteinโ€“protein interactions in living subjects
Authors: P. Ray, H. Pimenta, R. Paulmurugan, F. Berger, M.E. Phelps, M. Iyer, et al.
Journal: Proceedings of the National Academy of Sciences (PNAS), Vol. 99 (5), 3105โ€“3110

The emerging role of redox-sensitive Nrf2โ€“Keap1 pathway in diabetes
Authors: E. Bhakkiyalakshmi, D. Sireesh, P. Rajaguru, R. Paulmurugan, et al.
Journal: Pharmacological Research, Vol. 91, 104โ€“114

Ultrasound-guided delivery of microRNA loaded nanoparticles into cancer
Authors: T.Y. Wang, J.W. Choe, K. Pu, R. Devulapally, S. Bachawal, S. Machtaler, R. Paulmurugan, et al.
Journal: Journal of Controlled Release, Vol. 203, 99โ€“108

Effects of epigenetic modulation on reporter gene expression: implications for stem cell imaging
Authors: M. Krishnan, J.M. Park, F. Cao, D. Wang, R. Paulmurugan, J.R. Tseng, et al.
Journal: FASEB Journal, Vol. 20 (1), 106โ€“108

Firefly luciferase enzyme fragment complementation for imaging in cells and living animals
Authors: R. Paulmurugan, S.S. Gambhir
Journal: Analytical Chemistry, Vol. 77 (5), 1295โ€“1302

Molecular imaging of drug-modulated protein-protein interactions in living subjects
Authors: R. Paulmurugan, T.F. Massoud, J. Huang, S.S. Gambhir
Journal: Cancer Research, Vol. 64 (6), 2113โ€“2119

Detection of hepatitis E virus in raw and treated wastewater with the polymerase chain reaction
Authors: N. Jothikumar, K. Aparna, S. Kamatchiammal, R. Paulmurugan, et al.
Journal: Applied and Environmental Microbiology, Vol. 59 (8), 2558โ€“2562

Combinatorial library screening for developing an improved split-firefly luciferase fragment-assisted complementation system
Authors: R. Paulmurugan, S.S. Gambhir
Journal: Analytical Chemistry, Vol. 79 (6), 2346โ€“2353

Cell membrane-coated nanocarriers: the emerging targeted delivery system for cancer theranostics
Authors: R.J.C. Bose, R. Paulmurugan, J. Moon, S.H. Lee, H. Park
Journal: Drug Discovery Today, Vol. 23 (4), 891โ€“899

Mr Mohammed Amine ZITOUNI | Biomaterials | Best Researcher Award

Mr Mohammed Amine ZITOUNI | Biomaterials | Best Researcher Award

Mr. Mohammed Amine Zitouni is an Algerian researcher specializing in polymer chemistry and macromolecular organic chemistry. He was born on August 31, 1985, in Sabra, Tlemcen, Algeria. Currently pursuing a Ph.D. in Polymer Chemistry at the University of Tlemcen, he holds a strong academic foundation with a Magister degree and a postgraduate diploma in chemistry. Mr. Zitouni has engaged in both national and international scientific activities, including participation in major conferences across Algeria and Russia. His research focuses on novel hydrogel synthesis, polymeric drug delivery systems, and chitosan-based materials.

Mr Mohammed Amine ZITOUNI, Laboratory of Research on macromolecules, Department of Chemistry, Science Faculty, University of Tlemcen, Algeria

Profile

ORCID

๐ŸŽ“ Education

Mr. Mohammed Amine Zitouni has a strong academic foundation in chemistry and life sciences ๐Ÿ“˜๐Ÿงช. He earned his Bachelor’s degree in Natural and Life Sciences in June 2003 ๐ŸŽ“๐ŸŒฟ. He then pursued a Postgraduate Diploma in Chemistry from the University of Tlemcen in September 2007 ๐Ÿงฌ๐Ÿซ. In December 2010, he obtained a Magister’s degree specializing in Macromolecular Organic Chemistry and Physical Chemistry โš—๏ธ๐Ÿ“š. Currently, he is working toward a Ph.D. in Polymer Chemistry at the University of Tlemcen, focusing on advanced polymeric materials for biomedical applications ๐Ÿ”ฌ๐Ÿ“–. His education reflects a clear commitment to scientific advancement.

๐ŸŒ Scientific Activities

Mr. Mohammed Amine Zitouni has actively participated in national and international scientific forums ๐ŸŒ. He presented at the 10th International Conference of the European Chitin Society in Russia and major Algerian conferences like the CIMPCโ€™17 in Tlemcen and the National Seminar on Polymers in Bejaรฏa ๐ŸŽค๐Ÿงช. With one year in the university tutoring program and four years of teaching LMD ST practical work, he contributes to student development ๐ŸŽ“๐Ÿง‘โ€๐Ÿซ. His research led to international publications on chitosan/PVA hydrogels in Advanced Materials Research and Annales pharmaceutiques franรงaises, focusing on novel drug delivery systems ๐Ÿ“„๐Ÿ’Š.

๐Ÿ’ป Skills

Mr. Mohammed Amine Zitouni is a multilingual researcher with strong communication and technical skills ๐ŸŒ๐Ÿง . He is a native Arabic speaker, and is proficient in reading and writing in French and English, including technical scientific English for academic and research purposes ๐Ÿ“˜๐Ÿ“š. His language skills allow him to effectively engage with international research communities and contribute to global scientific discourse ๐ŸŒโœ๏ธ. In addition, he possesses excellent computer skills, demonstrating a perfect command of software tools and digital platforms essential for scientific research, data analysis, and academic publishing ๐Ÿง‘โ€๐Ÿ’ป๐Ÿ“Š.

๐Ÿ”ฌ Research Focus

Mr. Mohammed Amine Zitouniโ€™s research focuses on the synthesis and characterization of biopolymer-based hydrogels for pharmaceutical applications ๐Ÿงช๐Ÿ’Š. He develops advanced drug delivery systems using crosslinked chitosan and polyvinyl alcohol (PVA), aiming to enhance controlled release of antibiotics such as chlorotetracycline hydrochloride ๐Ÿ”„๐Ÿงซ. His work explores the physicochemical interactions within hydrogels to optimize stability, biocompatibility, and drug release efficiency ๐Ÿ“ˆ๐Ÿงฌ. This research holds significant promise for medical treatments requiring sustained delivery mechanisms and aligns with sustainable, biodegradable material innovation ๐ŸŒฑ๐Ÿ”. His expertise contributes to the intersection of polymer science and biomedical engineering ๐Ÿง ๐Ÿฅ.

๐Ÿ“˜ Publications

Preparation and characterization of hydrogels based on Chitosan/polyvinyl alcohol blends
Journal: Advanced Materials Research
Focus: Synthesis and structural analysis of biocompatible hydrogels for advanced material applications.
๐Ÿงช๐Ÿ’ง

Release of Chlorotetracycline Hydrochloride From Novel Hydrogels Based On Crosslinked Chitosan And PVA
Journal: Annales Pharmaceutiques Franรงaises
Focus: Controlled drug release systems using crosslinked hydrogels for pharmaceutical applications.
๐Ÿ’Š๐Ÿงฌ๐Ÿ“—

Sailee Chowdhury | Biomaterials | Best Researcher Award

Sailee Chowdhury | Biomaterials | Best Researcher Award

Prof Sailee Chowdhury, BCDA College of Pharmacy & Technology, India

Prof. Sailee Chowdhury is a distinguished academic and researcher in pharmaceutical technology with 17+ years of teaching experience ๐Ÿ“šโœจ. She holds a Ph.D. in Pharmaceutical Technology and has over 11 years of postdoctoral research experience. Her work spans flavonoids, nanoparticles, tissue engineering, and sustainable practices in drug discovery ๐ŸŒฟ๐Ÿ”ฌ. Prof. Chowdhury has published extensively in reputed journals and authored several book chapters, showcasing her commitment to knowledge dissemination ๐Ÿ“–. As Head of the Department, she leads with excellence in education and administration ๐Ÿซ๐ŸŽ“. Her active role in conferences and institutional committees reflects her influence and dedication to research ethics and innovation ๐ŸŒ๐Ÿ’ก.

Publication Profile

Scopus

Orcid

Educational Background ๐ŸŽ“

Prof. Sailee Chowdhury is a highly qualified academic with a Ph.D. in Pharmaceutical Technology from MAKAUT, Kolkata, awarded in 2013 ๐ŸŽ“๐Ÿ”ฌ. She holds an M.Pharm in Pharmaceutical Chemistry with First Class honors (SGPA 9) from Biju Pattnaik University of Technology (2006) ๐Ÿงช๐Ÿ“˜ and qualified GATE in 2004 ๐ŸŽฏ. Her academic journey began with a B.Pharm degree (Honors) scoring 80.3% from Burdwan University in 2004, followed by stellar performances in Higher Secondary (68%, WBCHSE, 2000) and Madhyamik (87%, WBBSE, 1998) ๐Ÿ“š๐ŸŒŸ. Prof. Chowdhuryโ€™s consistent academic excellence forms the foundation of her illustrious career in pharmaceutical education and research ๐ŸŒ๐Ÿ“–.

Professional Experience and Contributions ๐Ÿ’ผ

Prof. Sailee Chowdhury brings over 17 years of teaching experience at BCDA College of Pharmacy & Technology, Kolkata ๐ŸŽ“๐Ÿ“˜, where she has progressed through roles from Lecturer to Professor and currently serves as Head of the Department of Pharmaceutical Chemistry (since April 2022) ๐Ÿงช๐Ÿ”ฌ. Post-Ph.D., she has over 11 years of academic and research experience ๐ŸŒŸ. She actively contributes to UG and PG education, administrative roles, NBA accreditation, and institutional committees ๐Ÿ“Š๐Ÿ“œ. A recognized academic leader, she has organized national and international seminars, served as a reviewer for reputed journals and books, and contributed extensively to pharmaceutical education ๐ŸŒ๐Ÿ’ก.

Participation in Conference Seminar & Workshops ๐ŸŒ

Prof. Sailee Chowdhury has actively participated in numerous national and international conferences, seminars, and workshops, serving in roles such as Joint Convenor, Evaluator, Co-chairperson, Chairperson, Panelist, and Advisory Member ๐ŸŽค๐Ÿ“š. Highlights include the 72nd Indian Pharmaceutical Congress in Nagpur, the International Conference on Drug Discovery at Brainware University ๐ŸŒ๐Ÿ’Š, and multiple events organized by institutions like Jadavpur University and Amity University ๐Ÿงช๐Ÿ“–. She has chaired scientific sessions on medicinal plants and sustainable pharmaceutical practices, fostering academia-industry partnerships, and evaluating cutting-edge research, reflecting her commitment to advancing pharmaceutical education and research ๐ŸŒฑ๐Ÿ”ฌ.

Research Focus Area ๐ŸŒฑ๐Ÿงฌ

Prof. Sailee Chowdhury’s research spans pharmaceutical sciences, biomaterials, and sustainable innovation ๐ŸŒฟ๐Ÿ”ฌ. Her work includes the role of flavonoids and phenolics in gut microbiota modulation and combating metabolic diseases and biotic stress ๐Ÿฉบ๐Ÿƒ. She advances enzymology in drug discovery ๐Ÿ’Š๐Ÿงช, sustainable practices in the pharmaceutical industry ๐ŸŒโš—๏ธ, and plant-protein-based future foods ๐ŸŒฑ๐Ÿฝ๏ธ. Her expertise extends to cutting-edge biomaterials, exploring nanoparticles for gene expression and osteoconductivity ๐Ÿฆด๐Ÿงฌ, alginate biocomposites for drug delivery ๐Ÿฆ , and silk fibroin scaffolds for tissue engineering ๐Ÿงต๐Ÿ—๏ธ. This multidisciplinary focus aims to enhance healthcare, sustainability, and innovation, positioning her as a leader in pharmaceutical research. ๐ŸŒŸ๐Ÿ“˜

Publication Top Notes๐Ÿ“„โœจ

Flavonoids and their metabolites: Impact on gut microbiota in connection with chronic metabolic diseases

Phenolics as Shielding Counterparts from Plants to Combat Biotic Stress Mediated by Microbes and Nematodes

Enzymology in drug discovery

Sustainable Practices in the Pharmaceutical Industry: Development and Adoption

Applications of Modified Plant Protein-Based Future Foods

Nanoparticles for triggering gene expression and osteoconductivity

Biocomposites of Alginates in Drug Delivery

Silk Fibroinโ€“Based Biomaterial Scaffold in Tissue Engineering: Present Persuasive Perspective

Conclusion

Prof. Sailee Chowdhury demonstrates a holistic profile of academic excellence, significant research contributions, and impactful teaching and leadership roles. These attributes strongly position her as a suitable nominee for the Best Researcher Award. Her focus on innovative and sustainable pharmaceutical practices adds further value to her candidacy.

Dalia Zaafar | Biomaterials | Women Researcher Award

Dalia Zaafar | Biomaterials | Women Researcher Award

Assist. Prof. Dr Dalia Zaafar, Cairo University, Egypt

Dr. Dalia Zaafar is an Assistant Professor at Modern University for Technology and Information (MTI) in Egypt, specializing in pharmacology, toxicology, and clinical pharmacy. With a Ph.D. from Cairo University, she has led impactful research on cardiovascular pharmacology and oncology. ๐ŸŒ Her work includes clinical studies, focusing on metformin and sorafenib, contributing to drug safety. Dr. Zaafar is passionate about mentoring young researchers, especially women in academia, and has presented at international conferences. ๐ŸŽ“ She holds certifications in clinical practice and data analysis, enhancing her role as an expert in her field. ๐Ÿ“š

Publication Profile

Google Scholar

Orcid

Scopus

Educational Background ๐ŸŽ“

Dr. Dalia Zaafar holds a Ph.D. in Pharmacology and Toxicology from Cairo University (2019), with a focus on clinical studies and cardiovascular pharmacology. Her dissertation explored the efficacy and safety of dipeptidyl peptidase inhibitors versus Metformin in diabetic hypertensive patients. ๐ŸŽ“ She earned an M.A. in Pharmacology and Toxicology from Suez Canal University (2014), specializing in oncology and endocrinology. Dr. Zaafar also completed a Clinical Pharmacy diploma (2019-2021) in critical care and further honed her skills through a Data Analysis Professional Nano-degree (2021) and other specialized certifications in clinical pharmacology and pharmacoeconomics. ๐Ÿ“š๐Ÿ’ป

Current Role and Focus ๐Ÿ’ผ

Dr. Dalia Zaafar is an Assistant Professor at the Modern University for Technology and Information (MTI), Egypt, where she has been teaching and conducting research since 2019. ๐ŸŒŸ She designs experimental studies, collaborates internationally, and mentors young researchers. Additionally, she serves on the editorial boards of the Universal Journal of Pharmaceutical Research and the World Journal of Clinical Cases. ๐Ÿ“˜ Previously, she worked as a Clinical Pharmacist in critical care at Teacher’s Hospital and Abu Sower Medical Center. Dr. Zaafar has expertise in clinical pharmacy, research supervision, and interdisciplinary initiatives, fostering academic growth and innovation. ๐Ÿงช๐Ÿ‘ฉโ€๐Ÿซ

Participation in Conferences ๐ŸŒ

Dr. Dalia Zaafar was a speaker at the 18th International Conference of Biochemistry and Molecular Biology, held on September 16-17, 2023. ๐ŸŒ Her lecture, titled “Unravelling the Complexities of Tau Protein Dysfunction in Alzheimerโ€™s Disease: Pathophysiology, Biomarkers, and Therapeutic Perspectives”, highlighted groundbreaking insights into the mechanisms of Alzheimerโ€™s disease. ๐Ÿง ๐Ÿ”ฌ She discussed emerging biomarkers and innovative therapeutic strategies, contributing to a deeper understanding of this critical neurodegenerative condition. Dr. Zaafarโ€™s presentation underscored her expertise in molecular biology and her dedication to advancing research for a better future for humanity. ๐ŸŒŸ

Research Focus Area ๐ŸŒฑ๐Ÿงฌ

Dr. Dalia Zaafar’s research is focused on pharmacology, toxicology, and clinical pharmacy, with a multidisciplinary approach to tackling critical health challenges. ๐Ÿงช Her studies emphasize drug safety, cardiovascular pharmacology, and oncology, exploring innovative therapeutic interventions for diseases like Alzheimerโ€™s, Parkinsonโ€™s, colon cancer, and drug-induced toxicities. ๐Ÿ”ฌ Her work integrates molecular biology, nanotechnology, and experimental pharmacology, addressing mechanisms like tumor angiogenesis, neuroprotection, and signal pathway modulation. ๐ŸŒ Dr. Zaafar’s impactful contributions also span natural product-based therapies, nanoparticles for drug delivery, and biomarker development, making her a pioneer in advancing personalized medicine and enhancing treatment efficacy. ๐ŸŒŸ

Publication Top Notes๐Ÿ“š๐ŸŒ

Role of metformin in suppressing 1, 2-dimethylhydrazine-induced colon cancer in diabetic and non-diabetic mice: effect on tumor angiogenesis and cell proliferation

Hesperetin mitigates sorafenib-induced cardiotoxicity in mice through inhibition of the TLR4/NLRP3 signaling pathway

Selenium nanoparticles with prodigiosin rescue hippocampal damage associated with epileptic seizures induced by pentylenetetrazole in rats

Orexin pathway in Parkinsonโ€™s disease: a review

Discovery of new 1, 3, 4-oxadiazoles with dual activity targeting the cholinergic pathway as effective anti-Alzheimer agents

Comparing the effectiveness of L-carnitine and paraffin oil in acute aluminum phosphide poisoning using predictive biomarkers and scores: a randomized controlled clinical trial

Adherence to insulin therapy among children with type 1 diabetes: reliability and validity of the Arabic Version of the 4-Item Morisky Medication Adherence Scale

Combined ฮฒ-sitosterol and trimetazidine mitigate potassium dichromate-induced cardiotoxicity in rats through the interplay between NF-ฮบB/AMPK/mTOR/TLR4 and HO-1/NADPH signalingย โ€ฆ

Salixย subserrataย Bark ExtractLoaded Chitosan Nanoparticles Attenuate Neurotoxicity Induced by Sodium Arsenate in Rats in Relation with HPLCโ€“PDA-ESIโ€“MSย โ€ฆ

Conclusion ๐Ÿ”

Dr. Dalia Zaafarโ€™s dedication to research excellence, her leadership in mentoring young women researchers, and her impressive body of scholarly work make her a highly suitable candidate for the Women Researcher Award. Her contributions to pharmacology, particularly in clinical studies, and her active role in global research collaborations position her as an influential figure in the academic community.